US Patent Issued to Novartis on Nov. 25 for "Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,817, issued on Nov. 25, was assigned to Novartis AG (Basel, Switzerland).

"Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof" was invented by Rohan Eric John Beckwith (San Diego), Simone Bonazzi (Cambridge, Mass.), Artiom Cernijenko (Cambridge, Mass.), Philip Lam (Somerville, Mass.) and Noel Marie-France Thomsen (Chelmsford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a compound of Formula (I) or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R1, R2, Rx, X1, X2, X3, n, n1, and q are as defined herein, and methods of...